BIIB-101
- Generic Name
- BIIB-101
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ION464 Administered to Adults With Multiple System Atrophy (HORIZON)
- First Posted Date
- 2019-11-18
- Last Posted Date
- 2024-11-12
- Lead Sponsor
- Ionis Pharmaceuticals, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT04165486
- Locations
- 🇫🇷
CHU de Lyon - Hospices Civils de Lyon-H6pital Pierre Wertheimer, Neurologique HCL, Lyon, France
🇩🇪Klinikum der Universtiatet Muenchen -Campus Grosshadern, Muenchen, Germany
🇬🇧Salford Royal Hospital, Salford, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath